Background
Defining sarcopenia, cancer cachexia, and SO
Sarcopenia definition | Study | Functional component of definition | Body composition analysis method | Muscle mass definition | Pros | Cons | Obesity definition | Pros | Cons |
---|---|---|---|---|---|---|---|---|---|
ASM index >2 SDs below sex-specific means of Rosetta study reference data (Gallagher et al. 1997) | Baumgartner (Baumgartner et al. 1998) | – | DXA | ASM/m2 (Heymsfield et al. 1990) | – | No functional component | % body fat | Measures have been experimentally validated in comparison with BMI (Gallagher et al. 2000) Highly correlated with estimates from DXA (Baumgartner et al. 1998) | – |
Low gait speed or low handgrip strength with low muscle mass | Cruz-Jentoft (Cruz-Jentoft et al. 2010) | Gait speed ≤0.8 m/s or >0.8 m/s with handgrip strength below sex-specific cutoffs | – | – | Contains functional component, capturing more of sarcopenia due to poor muscle quality/fat infiltration | – | – | – | – |
Low gait speed or inability to rise from chair with low handgrip strength and body mass-adjusted ASM below sex-specific cutoffs | Studenski (Studenski et al. 2014) | Gait speed ≤0.8 m/s or inability to rise from a chair with handgrip strength below sex-specific cutoffs (men <26 kg, women <16 kg) | DXA | ASM/BMI | Contains functional component, capturing more of sarcopenia due to poor muscle quality/fat infiltration Recommendations based on the largest, most diverse samples to have been studied | – | BMI | Most common and widely available measure, easy to evaluate | Inaccurate, fluctuates with changes in both muscle and fat |
L3mi below sex-specific cutoffs associated with mortality in cohort obtained through optimum stratification | – | L3mi | – | No functional component | BMI | – | – | ||
Dello (Dello et al. 2013) | |||||||||
Voron (Voron et al. 2015) | |||||||||
Levolger (Levolger et al. 2015) | |||||||||
van Vledder (van Vledder et al. 2012) | Intra-abdominal fat (Yoshizumi et al. 1999) | Significantly associated with disease-free survival in men undergoing resection of colorectal liver metastases (van Vledder et al. 2012) | – | ||||||
Harimoto (Harimoto et al. 2013) | – | – | – | ||||||
Lodewick (Lodewick et al. 2015) | % body fat | – | – | ||||||
L3mi in the lowest sex-specific quartile | Miyamoto (Miyamoto et al. 2015) | – | Secondary analysis of CT images | L3mi | – | No functional component | – | – | – |
No specific cutoffs established (lower density reflects more frailty) | Sabel (Sabel et al. 2013) | – | Secondary analysis of CT images | PD | A measure of muscle quality or fat infiltration | No functional component | VF, SFD, TBF, or BMI | VF: risk factor for developing colorectal cancer and significantly associated with increased tumor recurrence in colorectal cancer patients (Moon et al. 2008) SFD: significant predictor of wound infection following colectomy for colon cancer (Sabel et al. 2013) TBF: significant predictor of outcome following colectomy for colon cancer (Sabel et al. 2013) | – |
TPA/m2 equal to or below cutoff obtained through optimum stratification | Peng (Peng et al. 2011) | – | Secondary analysis of CT images | TPA/m2
| – | No functional component | BMI | – | – |
TPA/m2 in the lowest sex-specific quartile | Peng (Peng et al. 2012) | – | Secondary analysis of CT images | TPA/m2
| – | No functional component | BMI | – | – |
Amini (Amini et al. 2015) | |||||||||
Joglekar (Joglekar et al. 2015) | |||||||||
TPV/m2 in the lowest sex-specific quartile | Amini (Amini et al. 2015) | – | Secondary analysis of CT image | TPV/m2
| Volumetric measure rather than cross-sectional assessment and which may be more accurate at assessing a larger sample of muscle mass | No functional component | BMI | – | – |
HUAC in the lowest sex-specific quartile | Joglekar (Joglekar et al. 2015) | – | Secondary analysis of CT image | HUAC | A measure of muscle quality or fat infiltration | No functional component | BMI | – | – |
Diagnosing sarcopenia and SO
Functional implications of SO
Impact of sarcopenia and SO on patient outcome
Colorectal cancer resection
Study | Cancer type | Association with short-term oncological outcomes? | Association with long-term oncological outcomes? | ||
---|---|---|---|---|---|
Sarcopenia | SO | Sarcopenia | SO | ||
Prado (Prado et al. 2008) | Respiratory or GI tract | – | Unclear, but associated with poorer functional status than in non-sarcopenic obese | Yes, independently predicted median survival | Yes, independently predicted survival |
Lieffers (Lieffers et al. 2012) | Colorectal (stages II–IV) | Yes, independently predicted post-operative infection risk, longer inpatient rehabilitation, associated with higher risk of obstruction, longer index hospitalization length of stay, longer mean length of stay overall | – | – | – |
Sabel (Sabel et al. 2013) | Colon | Yes, independently predicted surgical complications and infectious complications, associated with infectious post-operative complications | Unclear, but SFD is the best predictor of post-operative wound infections, and associated with infectious complications | No, not an independent predictor of disease-free or overall survival | Unclear, but TBF independently predicted disease-free survival |
Miyamoto (Miyamoto et al. 2015) | Colorectal (stages I–III) | – | – | Yes, independently associated with disease recurrence rate, overall mortality, cancer-specific mortality, recurrence-free survival, overall survival, cancer-specific survival | – |
van Vledder (van Vledder et al. 2012) | Colorectal liver metastases | – | – | Yes, independently predicted disease-free survival and overall survival | – |
Dello (Dello et al. 2013) | Colorectal liver metastases | Yes, independently predicted disproportionally small total functional liver volume | Unclear, but fat-free body mass and body surface area independently predicted disproportionally small total function liver volume | – | – |
Peng (Peng et al. 2011) | Colorectal liver metastases | Yes, independently predicted major post-operative complications, associated with risk of post-operative complications, overall morbidity risk, longer hospital stays, extended ICU stays | Yes, associated with major post-operative complications, longer hospital stays, extended ICU stays | No, not associated with recurrence-free survival, overall survival or risk of recurrence | No, not associated with overall survival or recurrence-free survival |
Lodewick (Lodewick et al. 2015) | Colorectal liver metastases | No, not significantly associated with risk of major post-operative complications, presence of liver surgery-specific composite endpointa (LSSCEP) items | No, not significantly associated with risk of major post-operative complications, occurrence of one or more of the LSSCEP items | No, not significantly associated with initial hospital length of stay, readmission rates, median disease-free survival, or overall survival | Yes, not predictive of initial hospital length of stay, disease-free survival, or overall survival, but significantly associated with readmission rates |
Harimoto (Harimoto et al. 2013) | Liver | Yes, independent predictor of liver dysfunction | – | Yes, independent predictor of overall and recurrence-free survival | – |
Voron (Voron et al. 2015) | Liver | No, not associated with severe post-operative complication rate, post-operative mortality or morbidity rates | – | Yes, independently associated with overall and disease-free survival | – |
Levolger (Levolger et al. 2015) | Liver | Yes, associated with major post-operative complication (Clavien-Dindo grade ≥IIIa) and treatment-related mortality (within 90 days post-treatment) | – | Yes, associated with overall survival, but not associated with disease-free survival | Yes, associated with shorter median survival |
Peng (Peng et al. 2012) | Pancreatic | No, not associated with overall morbidity, major post-operative complications, length of hospital stays, length of ICU stays, or hazard of 90-day death | – | Yes, independent predictor of 3-year mortality | – |
Amini (Amini et al. 2015) | Pancreatic | Yes, TPA-sarcopenia not associated with morbidity, but TPV-sarcopenia associated with post-operative complications, major complications, and length of hospital stay. TPV-sarcopenia also independently associated with post-operative complications | Yes, TPV-SO associated with post-operative complications | Yes, TPV-sarcopenia associated with risk of death, and independently associated with risk of death | – |
Joglekar (Joglekar et al. 2015) | Pancreatic | Yes, HUAC independently predicted length of stay, ICU stay, major grade III post-operative complications, incidence of any complications. TPA independently predicted length of stay | – | No, HUAC did not predict post-operative overall survival | – |